Shares of Abingdon Health Plc (LON:ABDX – Get Free Report) were up 0.8% on Thursday. The stock traded as high as GBX 11 and last traded at GBX 10.84. 109,810 shares were traded during trading, a decline of 53% from the average daily volume of 235,236 shares. The stock had previously closed at GBX 10.75.
Abingdon Health Stock Performance
The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The firm has a market capitalization of £27.40 million, a P/E ratio of -13.38 and a beta of 0.13. The stock has a fifty day moving average of GBX 10.76 and a 200-day moving average of GBX 10.46.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
